Collaborations & Alliances
Related Searches:
Filter by:
661 - 675 of 1104 results
December 28, 2009
Merck, through an affiliate, has decided to discontinue development of MK-1903 and ended its research collaboration with Arena.
Read More »
December 22, 2009
GSK buys into antibody-drug conjugate program, with max. payout of $390 million.
Read More »
December 22, 2009
AZ has acquired Biovitrum's leptin modulator program.
Read More »
December 22, 2009
Zymo will market Recothrom in all regions, except Canada.
Read More »
December 18, 2009
Astellas pays $40 million for Phase II AML treatment.
Read More »
December 17, 2009
GSK pays $10 million alliance after favorable candidate.
Read More »
December 16, 2009
Companies will combine on diabetes drug in Middle Kingdom
Read More »
December 15, 2009
Seattle Genetics and Millennium have entered into a development and commercialization agreement for lymphoma treatment brentuximab vedotin.
Read More »
December 11, 2009
Genentech has terminated its collaboration with Seattle Genetics for dacetuzumab.
Read More »
December 9, 2009
Pfizer and Crown Bioscience have entered into a collaboration to research and develop novel therapeutics for Asian cancers.
Read More »
December 3, 2009
AstraZeneca and Targacept have entered a collaboration and license agreement for the global development and commercialization of TC-5214.
Read More »
December 1, 2009
Pfizer and Protalix have entered into an agreement to develop and commercialize taliglucerase alfa
Read More »
November 25, 2009
Merck, through an affiliate, has extended its research collaboration with Idera Pharmaceuticals, Inc. for a fourth year.
Read More »
November 24, 2009
Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute formed a joint venture leveraging their collective technologies in the areas of oncology, metabolic disease and infectious diseases.
Read More »
November 23, 2009
Asterand has extended its collaboration with Bristol-Myers Squibb for as many as three years, for access to Asterand's PhaseZERO drug discovery services and XpressBANK of human tissue and clinical samples for validation of early drug targets and support f
Read More »
661 - 675 of 1104 results
